HemoVoid<\/a><\/strong><\/span> \u2013 a haemoglobin voiding strategy recommended for applications where haemoglobin is in relative high abundance ie erythrocyte lysates or whole blood.<\/p>\n Plus trial kits:\u00a0Hemoglobind Trial Kit<\/strong> <\/span><\/a>\u00a0and\u00a0HemoTrial Kit<\/a>.<\/strong><\/span><\/p>\n <\/p>\n The Hemoglobind\u2122<\/strong>\u00a0group of reagents for Haemoglobin Removal and Capture includes:<\/p>\n Poly-electrolytes are polymers with repeating units of stationary charges. HemogloBind\u2122\u00a0comes from a class of solid-phase, or surface-based, elastomeric poly-electrolytic surfaces\u00a0that bind proteins through an empirically derived chemistry combining elements of polymer\u00a0composition, cross-linking architecture and charge properties. As with bio-polymers like\u00a0DNA and Heparin, governing their reactivity is the spatial presentation of the electrostatic\u00a0groups along a flexible polymer chain.<\/p>\n Hemoglobind\u2122 has a high degree of specificity for hemoglobin, without cross-reacting with other\u00a0analytes. It can be used with the following samples to study analytical interferences, enzyme monitoring and blood substitutes:<\/p>\n HemogloBind\u2122 does not cross react with most common serum components, making it an\u00a0excellent tool in numerous applications. These include analytical protocols where optical\u00a0interference is problematic, such as bilirubin analysis and bulk serum clarification.\u00a0Haemoglobin variants, as in thalassemia, bind with differential affinity towards\u00a0HemogloBind\u2122. For purification and\/or analysis of haemoglobin, a modest elevation in pH will\u00a0facilitate desorption of hemoglobin bound to HemogloBind\u2122.<\/p>\n <\/p>\n Product Information<\/strong><\/p>\n Hemoglobind (5ml) – Product Code: H0145-05 Hemoglobind Trial Kit \u00a0(5 mL Hemoglobind & 5 preps of NuGel HemogloBind) – Product Code:\u00a0HB145K-05<\/a><\/span><\/p>\n Key Reference<\/strong> NuGel-Hemoglobind\u2122 is reengineered for increased stability. It is based on NuGel\u2122 silica (50 microns in size, 1000\u00c5) covalently bound to elastomeric polyelectrolytes. It binds >95% of hemoglobin from blood.<\/p>\n <\/p>\n Product Information<\/strong><\/p>\n NuGel-HemogloBind\u2122 (25 preps). Product Code: NP-HO-T25<\/a><\/span><\/p>\n NuGel-HemogloBind\u2122 (50 preps). Product Code: NP-HO-T50<\/a><\/span><\/p>\n Hemoglobind Trial Kit \u00a0(5 mL Hemoglobind & 5 preps of NuGel HemogloBind) – Product Code:\u00a0HB145K-05<\/a><\/span><\/p>\n <\/p>\n HemoVoid\u2122 , a silica-based protein enrichment matrix, removes hemoglobin from erythrocyte lysate samples while concentrating low abundance, and\/or low molecular weight proteins. The HemoVoid\u2122 protocol uses mild buffers; the protocol conditions are so gentle that native enzyme activity is retained in elution fractions. HemoVoid\u2122 derives from a silica-based library of individual mixed-mode ligand combinations (ionic, hydrophobic, aromatic, polymer). The library was designed to facilitate weak binding of proteins, allowing for rapid elution from the matrix without any foreknowledge of the variety of proteins contained in the starting sample. HemoVoid\u2122 depletes hemoglobin from red cell lysates while improving the resolution of less abundant blood proteins.<\/p>\n <\/p>\n Product Information<\/strong><\/p>\n HemoVoid\u2122 Kit (5 preps) Product Code: HVK-05<\/a><\/span><\/p>\n HemoVoid\u2122 Kit (10 preps) Product Code: HVK-10<\/a><\/span><\/p>\n HemoVoid\u2122 Kit (50 preps) Product Code: HVK-50<\/a><\/span><\/p>\n\n
Hemoglobind\u2122<\/strong> – a solution for\u00a0Haemoglobin Removal and Capture.<\/h4>\n
\n
![\"hemoglobind\"](\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/hemoglobind.png\")
<\/a><\/p>\n![\"hemoglobind2\"](\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/hemoglobind2.png\")
<\/a><\/p>\n
\n<\/a>Hemoglobind (15ml) – Product Code: H0145-15<\/a><\/span>
\n Hemoglobind (50ml) – Product Code: H0145-50<\/a><\/span><\/p>\n
\nParvathi S. Kumar, et al. Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats.\u00a0TRANSFUSION Volume 00, May 2016<\/a><\/span>.<\/p>\n<\/h4>\n
NuGel-HemogloBind\u2122 <\/strong>– Hemoglobin Capture Reagent From Blood and Hemolyzed Serum<\/h4>\n
\n
HemoVoid<\/strong> –\u00a0\u00a0Hemoglobin Depletion Reagent Kit<\/h4>\n
\n